ADSC injection via the tail vein to rodents 1 reduced serum ALT and AST levels and mortality [10] and 2 increased hepatic Akt and ERK1/2 phosphorylation and serum albumin levels [11], suggesting that ADSCs have a therapeutic effect on acute liver failure and can promote liver regeneration. Here, MAPK3 is linked to acute liver failure.